A New Approach to Clinical Care of Juvenile Idiopathic Arthritis: The Juvenile Arthritis Multidimensional Assessment Report
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Objective.: To develop and test a new multidimensional questionnaire for assessment of children with juvenile idiopathic arthritis (JIA) in standard clinical care. Methods.: The Juvenile Arthritis Multidimensional Assessment Report (JAMAR) includes 15 parent or patient-centered measures or items that assess well-being, pain, functional status, health-related quality of life, morning stiffness, disease activity, disease status and course, joint disease, extraarticular symptoms, side effects of medications, therapeutic compliance, and satisfaction with illness outcome. The JAMAR is proposed for use as both a proxy-report and a patient self-report, with the suggested age range of 7–18 years for use as a self-report. From March 2007 to September 2009, the questionnaire was completed by the parents of 618 children with JIA in 1814 visits and by 332 children in 749 visits. Results.: The JAMAR was found to be feasible and to possess face and content validity. All parents and children reported that the questionnaire was simple and easy to understand. Completion and scoring appeared to be quick, requiring < 15 minutes. There were very few missing data. Parents’ proxy-reported and children’s self-reported data were remarkably concordant. The JAMAR provided thorough information for the study patients about recent medical history and current health status. It performed similarly across different children’s ages and characterized the level of disease activity and disability well. Conclusion.: The development of the JAMAR introduces a new approach in pediatric rheumatology practice. This new questionnaire may help enhance the quality of care of children with JIA.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Measurement of health status in children with juvenile rheumatoid arthritis
Singh, G., Athreya, B. H., Fries, J. F., & Goldsmith, D. P. (1994) · Arthritis & Rheumatism · doi:10.1002/art.1780371209 · Cited by 838 · cited 1×
“(11) Listing of medications the child is taking.”
BackgroundVarni, J. W., Seid, M., Smith Knight, T., Burwinkle, T., Brown, J., & Szer, I. S. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10095 · Cited by 535
Patient-physician discordance in assessments of global disease severity in rheumatoid arthritis
Barton, J. L., Imboden, J., Graf, J., Glidden, D., Yelin, E. H., & Schillinger, D. (2010) · Arthritis Care & Research · doi:10.1002/acr.20132 · Cited by 191 · cited 3×
“5) 5 (2; 9) PRQL PhH score 0 (0; 2) 2 (1; 5) 4 (2; 8) 1 (0; 2) 3 (1; 5) 3 (1; 7) PRQL PsH score 0 (0; 2) 2 (0; 3) 3 (1; 5) 1 (0; 2) 2 (0.”
Background
Cited by
Juvenile Idiopathic Arthritis: Will Etanercept be an Improvement over Current Therapies?
De Benedetti, F., & Ravelli, A. (2000) · BioDrugs · doi:10.2165/00063030-200014020-00003 · Cited by 428
Self-citationMartini, A., Lovell, D. J., Albani, S., Brunner, H. I., Hyrich, K. L., Thompson, S. D., & Ruperto, N. (2022) · Nature Reviews Disease Primers · doi:10.1038/s41572-021-00332-8 · Cited by 289
Self-citationClinical outcome measures in juvenile idiopathic arthritis
Consolaro, A., Giancane, G., Schiappapietra, B., Davì, S., Calandra, S., Lanni, S., & Ravelli, A. (2016) · Pediatric Rheumatology · doi:10.1186/s12969-016-0085-5 · Cited by 245
“However, the JAMAR, in spite of its multidimensional nature, does not explore some relevant domains, e.g., fatigue or the impact of the disease in work-related issues.”
MethodSelf-citationConsolaro, A., Negro, G., Chiara Gallo, M., Bracciolini, G., Ferrari, C., Schiappapietra, B., Pistorio, A., Bovis, F., Ruperto, N., Martini, A., et al. (2014) · Arthritis Care & Research · doi:10.1002/acr.22393 · Cited by 175
“The clinical features of these patients have been described previously (10,12).”
BackgroundSelf-citation
Metadata
- Authors
- FILOCAMO, G., CONSOLARO, A., SCHIAPPAPIETRA, B., DALPRÀ, S., LATTANZI, B., MAGNI-MANZONI, S., RUPERTO, N., PISTORIO, A., PEDERZOLI, S., CIVINO, A., GUSEINOVA, D., MASALA, E., VIOLA, S., MARTINI, A., & RAVELLI, A.
- Venue
- The Journal of Rheumatology
- Publisher
- The Journal of Rheumatology
- Published
- 2011-03-01
- Volume
- 38
- Issue
- 5
- Pages
- 938-953
- ISSN
- 0315-162X (ISSN-L)
- 1499-2752
- OpenAlex
- W2319774300
- Cited by
- 179
- References
- 3
- FWCI
- 5.47
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.